Sirikan Rojanasarot
Biographic Data
| ID | 213760 |
|---|---|
| NAME | Sirikan Rojanasarot |
| GIVEN NAMES | Sirikan |
| FAMILY NAME | Rojanasarot |
| SIGNATURE | ROJANASAROT S |
| AFFILIATIONS | Boston Scientific (United States) |
| ORCID | 0000-0003-2102-7520 |
| VERIFIED | Yes |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2024 |
| LATEST PUBLICATION YEAR | 2024 |
| H-INDEX | 0 |
Improved Health Care Utilization Among Men With Depression Undergoing Inflatable Penile Prosthesis in a U.S. Commercial Population
We evaluated depression-related health care resource utilization and antidepressant prescription medication utilization among commercially insured men in the United States who underwent inflatable penile prosthesis (IPP) implantation between January 1, 2007 and December 31, 2020, and who received a depression diagnosis in the year preceding the IPP procedure. A total of 11,177 patients received an IPP during the index period, 808 of whom were dia…
Is Race Associated with the Surgical Treatment for Benign Prostatic Hyperplasia? An Analysis of 30,000 Medicare Lives
Backgrounds With an increased prevalence and burden of benign prostatic hyperplasia (BPH), effective and equitable treatment is a priority. Limited data exist evaluating treatment disparities for patients with BPH by race. This study examined the association between race and BPH surgical treatment rates among Medicare beneficiaries. Methods Medicare claims data were used to identify men newly diagnosed with BPH from January 1, 2010 through Decemb…
No prominent works on this page.
Improved Health Care Utilization Among Men With Depression Undergoing Inflatable Penile Prosthesis in a U.S. Commercial Population
We evaluated depression-related health care resource utilization and antidepressant prescription medication utilization among commercially insured men in the United States who underwent inflatable penile prosthesis (IPP) implantation between January 1, 2007 and December 31, 2020, and who received a depression diagnosis in the year preceding the IPP procedure. A total of 11,177 patients received an IPP during the index period, 808 of whom were dia…
Is Race Associated with the Surgical Treatment for Benign Prostatic Hyperplasia? An Analysis of 30,000 Medicare Lives
Backgrounds With an increased prevalence and burden of benign prostatic hyperplasia (BPH), effective and equitable treatment is a priority. Limited data exist evaluating treatment disparities for patients with BPH by race. This study examined the association between race and BPH surgical treatment rates among Medicare beneficiaries. Methods Medicare claims data were used to identify men newly diagnosed with BPH from January 1, 2010 through Decemb…
Internal Medicine (2 works) · Medicine (2 works) · Antidepressant (1 work) · Antidepressant medication (1 work) · Anxiety (1 work) · Discontinuation (1 work) · Emergency Medicine (1 work) · Epidemiology (1 work) · Erectile dysfunction (1 work) · Gender Studies (1 work)